Showing results (631-640 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|November 18, 2000
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11J M Gornet, D Azoulay, J C Duclos-Vallée, et al.
Anti-Cancer Drugs|March 23, 2001
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group StudyF Duffaud, M E van der Burg, M Namer, et al.
Anti-Cancer Drugs|January 6, 2001
The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinomaM H Neale, A Lamont, A Hindley, et al.
Anti-Cancer Drugs|April 6, 2001
Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patientsM Jagodic, T Cufer, B Zakotnik, et al.
Anti-Cancer Drugs|April 6, 2001
Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalatorsR T Dorr, J D Liddil, S M Sami, et al.
Anti-Cancer Drugs|April 6, 2001
Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosisT S Huang, C H Shu, Y Chao, et al.
Anti-Cancer Drugs|June 1, 2000
Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancerT Brodowicz, W J Koestler, S Tomek, et al.
Anti-Cancer Drugs|June 1, 2000
Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkagesA Rait, E Uhlmann, A Peyman, et al.
Anti-Cancer Drugs|June 1, 2000
Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1B T Hill, E Moran, C Etiévant, et al.
Anti-Cancer Drugs|June 1, 2000
Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograftM J Kelner, T C McMorris, L A Estes, et al.
Pageof 464